← Evidence map

ArticleFrontiers in pharmacology2023

Dysfunction of von-Hippel Lindau factor causes reduced degradation of HIF leading to renal cancer. Hypoxia-inducible factor-prolyl hydroxylase enzyme inhibitors also lessen HIF destruction and could therefore increase renal cancer.

Helge WaldumPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023

2024

this papercites it

Dysfunction of von-Hippel Lindau factor causes reduced degradation of HIF leading to renal cancer. Hypoxia-inducible factor-prolyl hydroxylase enzyme inhibitors also lessen HIF destruction and could therefore increase renal cancer. | Socratic